Julius Middleton Wilder, MD, PhD

Assistant Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail Box 90120, Durham, NC 27708-0120
Phone (919) 684-8111
Email address julius.wilder@duke.edu
In Their Words

Education and Training

  • Transplant Hepatology Fellowship, Medicine, Duke University School of Medicine, 2015 - 2016
  • DCRI Research Fellowship, Duke University School of Medicine, 2013 - 2016
  • Gastroenterology Fellowship, Medicine, Duke University School of Medicine, 2012 - 2015
  • Internal Medicine Residency, Medicine, Duke University School of Medicine, 2008 - 2011
  • M.D., Duke University School of Medicine, 2008
  • Ph.D., Duke University, 2007

Publications

Wilder, Julius M., Lennox J. Jeffers, Natarajan Ravendhran, Mitchell L. Shiffman, John Poulos, Mark S. Sulkowski, Norman Gitlin, et al. “Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data..” Hepatology 63, no. 2 (February 2016): 437–44. https://doi.org/10.1002/hep.28334.

PMID
26547499
Full Text

Wilder, Julius, Anirudh Saraswathula, Vic Hasselblad, and Andrew Muir. “A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial Enrollment..” J Natl Med Assoc 108, no. 1 (February 2016): 24–29. https://doi.org/10.1016/j.jnma.2015.12.004.

PMID
26928485
Full Text

Wilder, Julius M., and Andrew J. Muir. “Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes..” Ther Adv Chronic Dis 6, no. 6 (November 2015): 314–27. https://doi.org/10.1177/2040622315603642.

PMID
26568808
Full Text

Matta, Bassem, Julius Wilder, Tzu-Hao Lee, and Keyur Patel. “Predictive Performance of FIB 4 and APRI for Liver Fibrosis Assessment in Hepatitis C in Comparison to Transient Elastography.” In American Journal of Gastroenterology, 110:S885–S885. NATURE PUBLISHING GROUP, 2015.

Scholars@Duke

Matta, Bassem, Julius M. Wilder, Tzu-Hao Lee, and Keyur Patel. “Predictive value of APRI and FIB4 scores for liver fibrosis assessment in comparison to Transient Elastography in chronic hepatitis C patients.” In Hepatology, 62:1129A-1130A. WILEY-BLACKWELL, 2015.

Scholars@Duke

Oloruntoba, Omobonike O., Julius M. Wilder, Alastair D. Smith, Andrew J. Muir, and Cynthia A. Moylan. “The Influence of Race on Patient Preferences and Access to Orthotopic Liver Transplantation and Organ Donation.” In Hepatology, 60:963A-963A. WILEY-BLACKWELL, 2014.

Scholars@Duke

Jeffers, Lennox J., Julius M. Wilder, Andrew J. Muir, Charles Howell, Yanni Zhu, Star Seyedkazemi, Jenny C. Yang, Phillip S. Pang, John G. McHutchison, and K Rajender Reddy. “Safety and Efficacy of Ledipasvir/Sofosbuvir Single-Tablet-Regimen in African Americans with Genotype 1 Chronic Hepatitis C Virus: A Retrospective Analysis of Phase 3 Studies.” In Hepatology, 60:319A-320A. WILEY-BLACKWELL, 2014.

Scholars@Duke

Wilder, Julius, and Keyur Patel. “The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease..” Med Devices (Auckl) 7 (2014): 107–14. https://doi.org/10.2147/MDER.S46943.

PMID
24833926
Full Text

Saraswathula, Anirudh, Julius M. Wilder, and Andrew J. Muir. “A Systematic Review of Racial and Ethnic Diversity of Hepatitis C Virus Clinical Trials.” In Hepatology, 56:1087A-1087A. WILEY-BLACKWELL, 2012.

Scholars@Duke

Pages